Back to 
Sumitomo Mitsui Trust Group, Inc.
Sumitomo Mitsui Trust Group, Inc.
MCRB
Showing 0 of 15 quarters
Position history for Sumitomo Mitsui Trust Group, Inc.'s holdings in SERES THERAPEUTICS INC
No. Sumitomo Mitsui Trust Group exited its MCRB (Seres Therapeutics) position in Q3 2022. Its Q2 2022 13F listed 696,785 shares worth $2.4M. Sumitomo Mitsui Trust Group already held MCRB in its Q1 2019 13F, the earliest on record, and held it in 14 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.